Lupus Nephritis

Stem cells from cord blood are being investigated as a possible treatments for lupus nephritis. Click on the link provided to find out more about the trial. It remains too early to know if the approach will be suitable. We need evidence collected in clinical trials to determine if a proposed stem cell treatment is both safe and effective.

tagged as Lupus Nephritis

  • Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis Location: China
    Overview: This trial is investigating the effect of donated umbilical cord blood in the treatment lupus nephritis, an inflammation of the kidney caused by a disease of the immune system (systemic lupus erythematosus). Participants in the study will be divided into the control group which will receive standard treatment (immunosuppression with cyclo-phosphamide), or the treatment groups that will receive donated cord.  Patients and researchers will not know what group they were in. The trial is being conducted by Cytomed & Beike in conjunction with the Kunming Medical University in Yunan. Participants will be assessed six months after their treatment for either partial or complete remission of their nephritis.
    Link to Clinical Registry
    Trial Design: Safety and Efficacy Study
    Status: Open - Recruiting
    Stem Cell: Umbilical Cord Stem Cells